These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25939220)

  • 41. Venous Thromboembolism: New Concepts in Perioperative Management.
    Elisha S; Heiner J; Nagelhout J; Gabot M
    AANA J; 2015 Jun; 83(3):211-21. PubMed ID: 26137764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Venous thromboembolism and cancer].
    Meyer G
    Rev Prat; 2015 Feb; 65(2):216-9. PubMed ID: 25939227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic approach for patients with venous thromboembolism attended in emergency departments during routine clinical practice: the EDITH study.
    Ruiz-Artacho P; Piñera P; Antolin A; Casal JR; Sanchez M; Suero C; Merlo M; Carriel J; Genis M; Jimenez S
    J Comp Eff Res; 2018 Apr; 7(4):319-330. PubMed ID: 29570366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry.
    Galanaud JP; Trujillo-Santos J; Bikdeli B; Di Micco P; Bortoluzzi C; Bertoletti L; Pedrajas JM; Ballaz A; Alfonso J; Monreal M;
    J Thromb Thrombolysis; 2021 Aug; 52(2):532-541. PubMed ID: 33247808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments.
    Lenchus JD; Biehl M; Cabrera J; Moraes AG; Dezfulian C
    J Intensive Care Med; 2017 Jun; 32(5):299-311. PubMed ID: 27179058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of venous thrombo-embolism: an update.
    Konstantinides S; Torbicki A
    Eur Heart J; 2014 Nov; 35(41):2855-63. PubMed ID: 25179762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging options in the treatment of deep vein thrombosis and pulmonary embolism.
    Brenner B; Hoffman R
    Blood Rev; 2011 Sep; 25(5):215-21. PubMed ID: 21605928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
    Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
    Lefebvre P; Coleman CI; Bookhart BK; Wang ST; Mody SH; Tran KN; Zhuo DY; Huynh L; Nutescu EA
    J Med Econ; 2014 Jan; 17(1):52-64. PubMed ID: 24156243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current primary care practice in the diagnosis and management of patients with suspected venous thromboembolism and prescription of initiation dose of enoxaparin.
    Verhamme P; Motte S; Claes N; Verhaeghe R; Hermans C
    Int Angiol; 2010 Feb; 29(1):58-63. PubMed ID: 20224534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F; Kearon C
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
    Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
    Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venous thromboembolism. A review.
    Thorneycroft IH; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):911-20. PubMed ID: 14686028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological management of pulmonary embolism.
    Gouin B; Robert-Ebadi H; Righini M; Blondon M
    Expert Opin Pharmacother; 2017 Jan; 18(1):79-93. PubMed ID: 27917690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulant therapy for acute venous thromboembolism.
    Ermiş H; Ermiş N
    Turk Kardiyol Dern Ars; 2017 Sep; 45(6):563-571. PubMed ID: 28902651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-Life Management of Venous Thromboembolism With Rivaroxaban: Results From EXperience VTE, an Italian Epidemiological Survey.
    Imberti D; Barillari G;
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):241-247. PubMed ID: 28718296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.